• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫领域生物标志物的合理开发与应用:指导临床医生和研究人员的概念框架

Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers.

作者信息

Kolev Mirjam, Horn Michael P, Semmo Nasser, Nagler Michael

机构信息

Hepatology, University Clinic for Visceral Surgery and Medicine, Inselspital Bern, University of Bern, Bern, Switzerland.

Departement of Clinical Chemistry, Inselspital Bern, University of Bern, Bern, Switzerland.

出版信息

J Transl Autoimmun. 2022 Mar 6;5:100151. doi: 10.1016/j.jtauto.2022.100151. eCollection 2022.

DOI:10.1016/j.jtauto.2022.100151
PMID:35309737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8927991/
Abstract

Clear guidance is needed in the development and implementation of laboratory biomarkers in medicine. So far, no standardized phased approach is established that would pilot researchers and clinicians in this process. This leads to often incompletely validated biomarkers, which can bear the consequence of wrong applications, misinterpretation and inadequate management in the clinical context. In this conceptual article, we describe a stepwise approach to develop and comprehensively validate laboratory biomarkers. We will delineate basic steps including technical performance, pre-analytical issues, and biological variation, as well as advanced aspects of biomarker utility comprising interpretability, diagnostic and prognostic accuracy, and health-care outcomes. These aspects will be illustrated by using well-known examples from the field of immunology. The application of this conceptual framework will guide researchers in conducting meaningful projects to develop and evaluate biomarkers for the use in clinical practice. Furthermore, clinicians will be able to adequately interpret pre-clinical and clinical diagnostic literature and rationally apply biomarkers in clinical practice. Improvement in the implementation and application of biomarkers might relevantly change the management and outcomes of our patients for the better.

摘要

医学领域实验室生物标志物的开发与应用需要明确的指导。到目前为止,尚未建立标准化的分阶段方法来指导研究人员和临床医生开展这一过程。这常常导致生物标志物验证不充分,可能会在临床环境中产生错误应用、错误解读和管理不当的后果。在这篇概念性文章中,我们描述了一种逐步开发和全面验证实验室生物标志物的方法。我们将阐述包括技术性能、分析前问题和生物学变异等基本步骤,以及生物标志物效用的高级方面,包括可解释性、诊断和预后准确性以及医疗保健结果。这些方面将通过免疫学领域的知名例子进行说明。这一概念框架的应用将指导研究人员开展有意义的项目,以开发和评估用于临床实践的生物标志物。此外,临床医生将能够充分解读临床前和临床诊断文献,并在临床实践中合理应用生物标志物。生物标志物实施和应用的改进可能会显著改善我们患者的管理和治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f672/8927991/d6e764083660/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f672/8927991/c0652108fd60/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f672/8927991/d6e764083660/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f672/8927991/c0652108fd60/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f672/8927991/d6e764083660/gr2.jpg

相似文献

1
Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers.自身免疫领域生物标志物的合理开发与应用:指导临床医生和研究人员的概念框架
J Transl Autoimmun. 2022 Mar 6;5:100151. doi: 10.1016/j.jtauto.2022.100151. eCollection 2022.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
4
Translating Laboratory Tests into Clinical Practice: A Conceptual Framework.将实验室检查转化为临床实践:概念框架。
Hamostaseologie. 2020 Nov;40(4):420-429. doi: 10.1055/a-1227-8008. Epub 2020 Sep 22.
5
Method/ology of Phases of Biomarker Discovery.生物标志物发现阶段的方法/学。
Hosp Pediatr. 2023 Jul 1;13(7):e181-e185. doi: 10.1542/hpeds.2022-007012.
6
[Evidence-based laboratory medicine].[循证检验医学]
Orv Hetil. 2003 May 4;144(18):869-76.
7
Reducing disparity in behavioral health services: a report from the American College of Mental Health Administration.减少行为健康服务中的差距:美国心理健康管理学院的一份报告。
Adm Policy Ment Health. 2004 Jan;31(3):253-63. doi: 10.1023/b:apih.0000018833.22506.fc.
8
9
Primary Care Research Team Assessment (PCRTA): development and evaluation.基层医疗研究团队评估(PCRTA):开发与评估
Occas Pap R Coll Gen Pract. 2002 Feb(81):iii-vi, 1-72.
10
High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.高敏心肌肌钙蛋白检测:从改善分析性能到提高风险分层。
Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1.

本文引用的文献

1
How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.如何报告 HEp-2 细胞抗核抗体(抗细胞抗体)检测:来自 ICAP 倡议的指南。
Immunol Res. 2021 Dec;69(6):594-608. doi: 10.1007/s12026-021-09233-0. Epub 2021 Oct 9.
2
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.在真实临床环境中 SARS-CoV-2 快速抗原检测的诊断准确性。
Int J Infect Dis. 2021 Aug;109:118-122. doi: 10.1016/j.ijid.2021.07.010. Epub 2021 Jul 7.
3
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.
研究设计、实施和数据分析中的偏倚会扭曲对临床获益的评估和 ESMO-MCBS 评分。
ESMO Open. 2021 Jun;6(3):100117. doi: 10.1016/j.esmoop.2021.100117. Epub 2021 Apr 20.
4
Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.在自动化计算机辅助 HEp-2 免疫荧光检测系统视角下的标准化和质量评估。
Front Immunol. 2021 Feb 25;12:638863. doi: 10.3389/fimmu.2021.638863. eCollection 2021.
5
Translating Laboratory Tests into Clinical Practice: A Conceptual Framework.将实验室检查转化为临床实践:概念框架。
Hamostaseologie. 2020 Nov;40(4):420-429. doi: 10.1055/a-1227-8008. Epub 2020 Sep 22.
6
Quality and best practice in medical laboratories: specific requests for autoimmunity testing.医学实验室的质量与最佳实践:自身免疫检测的特定要求
Auto Immun Highlights. 2020 Sep 3;11(1):12. doi: 10.1186/s13317-020-00134-0.
7
Rapid Centrifugation in the Routine Hemostasis Laboratory.常规止血实验室的快速离心。
Thromb Haemost. 2019 Dec;119(12):2025-2033. doi: 10.1055/s-0039-1696712. Epub 2019 Oct 10.
8
The challenges of primary biliary cholangitis: What is new and what needs to be done.原发性胆汁性胆管炎的挑战:新的挑战和需要做的事情。
J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20.
9
Comprehensive Integration of Single-Cell Data.单细胞数据的综合整合。
Cell. 2019 Jun 13;177(7):1888-1902.e21. doi: 10.1016/j.cell.2019.05.031. Epub 2019 Jun 6.
10
Next-generation sequencing and its clinical application.下一代测序技术及其临床应用。
Cancer Biol Med. 2019 Feb;16(1):4-10. doi: 10.20892/j.issn.2095-3941.2018.0055.